CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
D000071443:12E7 Antigen; D000293:Adolescent; D015703:Antigens, CD / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D001856:Bone Marrow Examination; D015815:Cell Adhesion Molecules / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D004253:DNA Nucleotidylexotransferase / Q000032:analysis; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007223:Infant; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000175:diagnosis*; D008297:Male; D025202:Molecular Diagnostic Techniques; D018365:Neoplasm, Residual / Q000175:diagnosis*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis*; D012680:Sensitivity and Specificity; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000071443:12E7 Antigen; D015703:Antigens, CD; D014408:Biomarkers, Tumor; C061828:CD99 protein, human; D015815:Cell Adhesion Molecules; D004253:DNA Nucleotidylexotransferase